These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12403958)

  • 1. Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial.
    Bogousslavsky J; Victor SJ; Salinas EO; Pallay A; Donnan GA; Fieschi C; Kaste M; Orgogozo JM; Chamorro A; Desmet A;
    Cerebrovasc Dis; 2002; 14(3-4):239-51. PubMed ID: 12403958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trafermin for stroke recovery: is it time for another randomized clinical trial?
    Paciaroni M; Bogousslavsky J
    Expert Opin Biol Ther; 2011 Nov; 11(11):1533-41. PubMed ID: 21883031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II).
    Adams HP; Effron MB; Torner J; Dávalos A; Frayne J; Teal P; Leclerc J; Oemar B; Padgett L; Barnathan ES; Hacke W;
    Stroke; 2008 Jan; 39(1):87-99. PubMed ID: 18032739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.
    Kitamura M; Akamatsu M; Kawanami M; Furuichi Y; Fujii T; Mori M; Kunimatsu K; Shimauchi H; Ogata Y; Yamamoto M; Nakagawa T; Sato S; Ito K; Ogasawara T; Izumi Y; Gomi K; Yamazaki K; Yoshie H; Fukuda M; Noguchi T; Takashiba S; Kurihara H; Nagata T; Hamachi T; Maeda K; Yokota M; Sakagami R; Hara Y; Noguchi K; Furuuchi T; Sasano T; Imai E; Ohmae M; Koizumi H; Watanuki M; Murakami S
    J Bone Miner Res; 2016 Apr; 31(4):806-14. PubMed ID: 26547659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.
    Diener HC; Cortens M; Ford G; Grotta J; Hacke W; Kaste M; Koudstaal PJ; Wessel T
    Stroke; 2000 Nov; 31(11):2543-51. PubMed ID: 11062273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
    Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators
    Stroke; 2005 Apr; 36(4):880-90. PubMed ID: 15731473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT).
    Teal P; Davis S; Hacke W; Kaste M; Lyden PD; ; Fierus M;
    Stroke; 2009 Nov; 40(11):3518-25. PubMed ID: 19745176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.
    Lees KR; Bornstein N; Diener HC; Gorelick PB; Rosenberg G; Shuaib A;
    Stroke; 2013 Mar; 44(3):580-4. PubMed ID: 23391764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial.
    Cooperative Group for Reassessment of Defibrase
    Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.
    Rosenberg G; Bornstein N; Diener HC; Gorelick PB; Shuaib A; Lees K;
    Int J Stroke; 2011 Aug; 6(4):362-7. PubMed ID: 21645269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II Trial of Intravenous Low-Dose Granulocyte Colony-Stimulating Factor in Acute Ischemic Stroke.
    Mizuma A; Yamashita T; Kono S; Nakayama T; Baba Y; Itoh S; Asakura K; Niimi Y; Asahi T; Kanemaru K; Mutoh T; Kuroda S; Kinouchi H; Abe K; Takizawa S
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1451-7. PubMed ID: 27017282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
    Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
    Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
    Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
    Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial.
    Torgano G; Zecca B; Monzani V; Maestroni A; Rossi P; Cazzaniga M; Manganaro D; Boiti C; Zilioli E; Borutti G; Falaschi F; Mandelli C
    Cerebrovasc Dis; 2010 Feb; 29(3):275-81. PubMed ID: 20090319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine antagonist (GV150526) in acute stroke: a multicentre, double-blind placebo-controlled phase II trial.
    Lees KR; Lavelle JF; Cunha L; Diener HC; Sanders EA; Tack P; Wester P;
    Cerebrovasc Dis; 2001; 11(1):20-9. PubMed ID: 11173790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.